Russell C Dale Selected Research

Basal Ganglia Diseases (Basal Ganglia Disease)

1/2020	Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders.
11/2012	Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
11/2012	Autoimmune basal ganglia disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Russell C Dale Research Topics

Disease

43	Encephalitis (Encephalitis, Rasmussen) 01/2024 - 01/2004
22	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 02/2007
21	Seizures (Absence Seizure) 01/2023 - 06/2008
20	Inflammation (Inflammations) 11/2023 - 04/2009
16	Brain Diseases (Brain Disorder) 01/2023 - 06/2009
16	Autoimmune Diseases of the Nervous System 03/2021 - 09/2010
15	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2024 - 10/2005
15	Neuromyelitis Optica (Devic's Disease) 01/2023 - 06/2009
14	Multiple Sclerosis 01/2023 - 02/2007
14	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2021 - 05/2014
12	Chorea (Rheumatic Chorea) 04/2024 - 03/2003
11	Optic Neuritis (Retrobulbar Neuritis) 01/2024 - 06/2009
11	Movement Disorders (Movement Disorder) 01/2024 - 09/2010
11	Epilepsy (Aura) 05/2023 - 06/2003
11	Neuroinflammatory Diseases 05/2023 - 07/2014
9	Central Nervous System Diseases (CNS Diseases) 01/2017 - 06/2003
8	Infections 01/2023 - 07/2014
8	Dystonia (Limb Dystonia) 11/2022 - 04/2009
7	Nervous System Diseases (Neurological Disorders) 06/2024 - 11/2011
7	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 06/2009
6	Parkinsonian Disorders (Parkinsonism) 11/2022 - 06/2011
6	Glioma (Gliomas) 10/2021 - 11/2011
6	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2021 - 06/2003
5	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 11/2011
5	Disease Progression 02/2022 - 12/2014
5	Mental Disorders (Mental Disorder) 01/2020 - 11/2012
4	Stroke (Strokes) 01/2023 - 01/2019
4	Herpes Simplex Encephalitis (Herpes Encephalitis) 03/2022 - 04/2007
4	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 06/2003
4	Human Influenza (Influenza) 01/2019 - 01/2004
4	Ataxia (Dyssynergia) 11/2017 - 06/2003
4	Psychotic Disorders (Schizoaffective Disorder) 09/2015 - 08/2011
3	Ischemic Stroke 03/2024 - 01/2019
3	Leukocytosis (Pleocytosis) 05/2023 - 04/2009
3	Spasm (Spasms) 10/2022 - 11/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 08/2010
3	Myasthenia Gravis 01/2021 - 03/2011
3	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2020 - 11/2012
3	Myoclonic dystonia 01/2019 - 08/2011
3	Myelitis 01/2019 - 04/2009
3	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2018 - 08/2010
3	Dyskinesias (Dyskinesia) 04/2017 - 01/2013
2	COVID-19 01/2024 - 01/2021
2	Aseptic Meningitis 12/2022 - 01/2013
2	Hyperkinesis 11/2022 - 04/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 07/2007
2	Autism Spectrum Disorder 01/2022 - 12/2017
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 10/2005
2	Tourette Syndrome (Tourette's Syndrome) 01/2022 - 11/2012

Drug/Important Bio-Agent (IBA)

43	AntibodiesIBA 01/2024 - 06/2003
39	AutoantibodiesIBA 01/2024 - 03/2003
30	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 11/2009
26	Myelin-Oligodendrocyte GlycoproteinIBA 01/2024 - 12/2009
22	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2009
16	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2011
12	Immunoglobulin G (IgG)IBA 01/2024 - 04/2007
11	CytokinesIBA 12/2022 - 01/2016
9	SteroidsIBA 12/2022 - 05/2004
8	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 08/2009
8	NeopterinIBA 05/2023 - 04/2009
8	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 06/2003
8	AntigensIBA 01/2021 - 12/2009
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 10/2016 - 11/2011
6	Leucine (L-Leucine)FDA Link 10/2021 - 11/2011
6	ChemokinesIBA 01/2019 - 01/2016
5	EpitopesIBA 01/2024 - 10/2013
5	KynurenineIBA 05/2023 - 01/2021
5	Rituximab (Mabthera)FDA Link 10/2021 - 06/2011
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2013
5	Oligoclonal BandsIBA 04/2015 - 11/2007
5	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 11/2007
4	Tryptophan (L-Tryptophan)FDA Link 05/2023 - 01/2021
4	Quinolinic AcidIBA 05/2023 - 01/2021
4	Kynurenic Acid (Kynurenate)IBA 05/2023 - 01/2021
4	N-Methylaspartate (NMDA)IBA 03/2022 - 09/2010
4	InterferonsIBA 01/2022 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2016
3	Glycine Receptors (Glycine Receptor)IBA 01/2024 - 12/2013
3	AutoantigensIBA 01/2023 - 03/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2004
3	AcidsIBA 01/2021 - 01/2015
3	Aminobutyrates (Aminobutyric Acid)IBA 01/2020 - 01/2015
3	Antiviral Agents (Antivirals)IBA 11/2017 - 10/2012
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2016 - 06/2013
3	Surface Antigens (Surface Antigen)IBA 01/2015 - 06/2011
2	C-Reactive ProteinIBA 01/2024 - 05/2015
2	Interleukin-10 (Interleukin 10)IBA 12/2022 - 01/2016
2	Dopamine Agents (Dopaminergic Agents)IBA 11/2022 - 11/2007
2	Arginine (L-Arginine)FDA Link 03/2022 - 01/2021
2	anthranilic acid (anthranilate)IBA 03/2022 - 01/2021
2	CitrullineIBA 03/2022 - 01/2021
2	3-Hydroxyanthranilic AcidIBA 03/2022 - 01/2021
2	Immunoglobulin A (IgA)IBA 01/2022 - 03/2015

Therapy/Procedure

27	Therapeutics 06/2024 - 06/2003
11	Immunotherapy 04/2024 - 11/2011
4	Deep Brain Stimulation 11/2022 - 04/2017
4	Plasma Exchange 08/2016 - 06/2011
2	Thrombectomy 03/2024 - 01/2023
2	Ketogenic Diet 11/2022 - 10/2022